Antibe Therapeutics Balance Sheet Health

Financial Health criteria checks 6/6

Antibe Therapeutics has a total shareholder equity of CA$25.9M and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$56.4M and CA$30.4M respectively.

Key information

0%

Debt to equity ratio

CA$0

Debt

Interest coverage ration/a
CashCA$24.91m
EquityCA$25.94m
Total liabilitiesCA$30.43m
Total assetsCA$56.36m

Recent financial health updates

Recent updates

Is Antibe Therapeutics (TSE:ATE) In A Good Position To Invest In Growth?

Dec 15
Is Antibe Therapeutics (TSE:ATE) In A Good Position To Invest In Growth?

We Think Antibe Therapeutics (TSE:ATE) Needs To Drive Business Growth Carefully

Mar 20
We Think Antibe Therapeutics (TSE:ATE) Needs To Drive Business Growth Carefully

Antibe Therapeutics (TSE:ATE) Is In A Strong Position To Grow Its Business

Oct 16
Antibe Therapeutics (TSE:ATE) Is In A Strong Position To Grow Its Business

Antibe Therapeutics Inc.'s (TSE:ATE) Profit Outlook

Feb 11
Antibe Therapeutics Inc.'s (TSE:ATE) Profit Outlook

We're Keeping An Eye On Antibe Therapeutics' (TSE:ATE) Cash Burn Rate

Jan 07
We're Keeping An Eye On Antibe Therapeutics' (TSE:ATE) Cash Burn Rate

Auditors Are Concerned About Antibe Therapeutics (CVE:ATE)

Jul 31
Auditors Are Concerned About Antibe Therapeutics (CVE:ATE)

Need To Know: The Consensus Just Cut Its Antibe Therapeutics Inc. (CVE:ATE) Estimates For 2021

Jul 29
Need To Know: The Consensus Just Cut Its Antibe Therapeutics Inc. (CVE:ATE) Estimates For 2021

Financial Position Analysis

Short Term Liabilities: ATE's short term assets (CA$28.1M) exceed its short term liabilities (CA$2.8M).

Long Term Liabilities: ATE's short term assets (CA$28.1M) exceed its long term liabilities (CA$27.6M).


Debt to Equity History and Analysis

Debt Level: ATE is debt free.

Reducing Debt: ATE has no debt compared to 5 years ago when its debt to equity ratio was 35.8%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ATE has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: ATE has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 14.9% each year.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.